CD8A and viral infectious disease: Thus, therapies aimed at dampening pDC responses to limit immunopathology in the course of viral infections should be combined with other treatments aimed at controling viral replication, such as antiviral drugs or immunotherapeutic restoration of the cytotoxic antiviral activity of NK cells or CD8 T lymphocytes.